• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased immunosuppressive vulnerability in elderly renal transplant recipients.

作者信息

Meier-Kriesche H U, Ojo A, Hanson J, Cibrik D, Lake K, Agodoa L Y, Leichtman A, Kaplan B

机构信息

Department of Internal Medicine, University of Michigan Health System, Ann Arbor 48109-0364, USA.

出版信息

Transplantation. 2000 Mar 15;69(5):885-9. doi: 10.1097/00007890-200003150-00037.

DOI:10.1097/00007890-200003150-00037
PMID:10755545
Abstract
摘要

相似文献

1
Increased immunosuppressive vulnerability in elderly renal transplant recipients.老年肾移植受者免疫抑制易感性增加。
Transplantation. 2000 Mar 15;69(5):885-9. doi: 10.1097/00007890-200003150-00037.
2
Outcomes of Kidney Transplantation Abroad: A Single-Center Canadian Cohort Study.国外肾移植的结果：一项加拿大单中心队列研究。
Prog Transplant. 2016 Mar;26(1):5-12. doi: 10.1177/1526924816632133.
3
Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.白细胞介素-2 受体抗体并不能降低低免疫风险或他克莫司治疗的中免疫风险肾移植受者的排斥风险。
Nephrology (Carlton). 2010 Apr;15(3):368-76. doi: 10.1111/j.1440-1797.2009.01259.x.
4
Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.评估兔抗胸腺细胞球蛋白诱导疗法在老年肾移植受者中的安全性和有效性。
Exp Clin Transplant. 2013 Jun;11(3):222-8. doi: 10.6002/ect.2012.0211. Epub 2013 Feb 22.
5
Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients.儿童及青少年肾移植受者的诱导治疗、排斥反应及移植结局
Transplantation. 2017 Sep;101(9):2146-2151. doi: 10.1097/TP.0000000000001577.
6
Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?在老年肾移植受者中，霉酚酸酯比硫唑嘌呤的安全性更低吗？
Transplantation. 2002 Apr 15;73(7):1158-63. doi: 10.1097/00007890-200204150-00027.
7
Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.与肾移植受者相比，胰肾联合移植受者患鳞状细胞癌的风险增加。
J Invest Dermatol. 2009 Dec;129(12):2886-94. doi: 10.1038/jid.2009.181. Epub 2009 Jul 2.
8
Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients.肾移植受者免疫抑制药物治疗依从性的风险因素
Transplant Proc. 2003 Nov;35(7):2609-11. doi: 10.1016/j.transproceed.2003.09.047.
9
CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.肾移植后淋巴组织增生性疾病停用钙调神经磷酸酶抑制剂是移植物失功和死亡的独立危险因素。
Transpl Int. 2014 Sep;27(9):956-65. doi: 10.1111/tri.12375. Epub 2014 Aug 20.
10
Need for individualized immunosuppression in elderly renal transplant recipients.老年肾移植受者个体化免疫抑制的必要性。
Transplant Proc. 2001 Feb-Mar;33(1-2):1190-1. doi: 10.1016/s0041-1345(00)02380-0.

引用本文的文献

1
Association Between Perioperative Hypotension and Graft Function in Kidney Transplantation.肾移植围手术期低血压与移植肾功能之间的关联
Kidney Int Rep. 2025 Apr 1;10(6):1819-1828. doi: 10.1016/j.ekir.2025.03.055. eCollection 2025 Jun.
2
Necessity of induction agent modification for old age kidney transplant recipients.老年肾移植受者诱导剂调整的必要性。
Kidney Res Clin Pract. 2025 Mar;44(2):349-360. doi: 10.23876/j.krcp.23.068. Epub 2023 Nov 1.
3
The aging of the immune system and its implications for transplantation.
免疫系统的衰老及其对移植的影响。
Geroscience. 2023 Jun;45(3):1383-1400. doi: 10.1007/s11357-022-00720-2. Epub 2023 Jan 10.
4
Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study.他克莫司单药治疗在免疫低危肾移植受者中是安全的：一项随机对照的初步研究。
Transpl Int. 2022 Oct 24;35:10839. doi: 10.3389/ti.2022.10839. eCollection 2022.
5
Heart Transplantation With Older Donors: Should There Be an Age Cutoff?心脏移植供体的年龄限制：是否应该设定年龄上限？
Transplant Proc. 2022 Oct;54(8):2088-2096. doi: 10.1016/j.transproceed.2022.07.004. Epub 2022 Oct 1.
6
Impact of delayed graft function on clinical outcomes in highly sensitized patients after deceased-donor kidney transplantation.延迟移植肾功能对高敏患者尸体供肾移植术后临床结局的影响。
Korean J Transplant. 2021 Sep 30;35(3):149-160. doi: 10.4285/kjt.21.0014.
7
Elderly kidney transplant recipients have favorable outcomes but increased infection-related mortality.老年肾移植受者有良好的预后，但与感染相关的死亡率增加。
Kidney Res Clin Pract. 2022 May;41(3):372-383. doi: 10.23876/j.krcp.21.207. Epub 2022 Feb 23.
8
The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age.诱导治疗方案的选择对肾移植术后结局的影响因受者年龄而异。
Transplant Direct. 2021 Jun 18;7(7):e715. doi: 10.1097/TXD.0000000000001105. eCollection 2021 Jul.
9
Immunosuppression Considerations for Older Kidney Transplant Recipients.老年肾移植受者的免疫抑制考量
Curr Transplant Rep. 2021 Jun;8(2):100-110. doi: 10.1007/s40472-021-00321-6. Epub 2021 Apr 6.
10
Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients.老年肾移植受者使用钙调神经磷酸酶抑制剂的药代动力学和药效学考量
Front Pharmacol. 2021 Apr 12;12:635165. doi: 10.3389/fphar.2021.635165. eCollection 2021.